Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03834688
Title Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405)
Acronym PrE0405
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PrECOG, LLC.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.